SCHEMBL15740306

SCHEMBL15740306

CC(C)(C)OC(=O)N1C(c2cc(F)c(N)[nH]c2=O)[C@@H]2OC(C)(C)O[C@@H]2[C@H]1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17175109 0.84 — —
SCHEMBL15718993 0.83 — —
SCHEMBL15718894 0.83 — —
SCHEMBL17175110 0.82 — —
SCHEMBL17178699 0.81 — —
SCHEMBL17178449 0.80 ABCB1 (0.30) —
SCHEMBL15740122 0.79 — —
SCHEMBL15740208 0.79 — —
SCHEMBL15740209 0.78 — —
SCHEMBL19671136 0.78 KDM4E (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3251674-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BioCryst Pharmaceuticals, Inc. (US) 2017-12-06 — — EP disclosed
US-20170267681-A1 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES MIDCAP FINANCIAL TRUST, AS AGENT 2017-09-21 — — US disclosed
US-20150291596-A1 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BIOCRYST PHARMACEUTICALS, INC. 2015-10-15 — — US disclosed
WO-2014078778-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BIOCRYST PHARMACEUTICALS, INC. (US) 2014-05-22 — — WO disclosed
Send feedback